583 related articles for article (PubMed ID: 29672690)
1. Infections and associated costs following cardiovascular implantable electronic device implantations: a nationwide cohort study.
Clémenty N; Carion PL; Léotoing L; Lamarsalle L; Wilquin-Bequet F; Brown B; Verhees KJP; Fernandes J; Deharo JC
Europace; 2018 Dec; 20(12):1974-1980. PubMed ID: 29672690
[TBL] [Abstract][Full Text] [Related]
2. Infective endocarditis and risk of death after cardiac implantable electronic device implantation: a nationwide cohort study.
Özcan C; Raunsø J; Lamberts M; Køber L; Lindhardt TB; Bruun NE; Laursen ML; Torp-Pedersen C; Gislason GH; Hansen ML
Europace; 2017 Jun; 19(6):1007-1014. PubMed ID: 28073883
[TBL] [Abstract][Full Text] [Related]
3. Implantation and patient profiles for pacemakers and cardioverter-defibrillators in France (2008-2009).
Tuppin P; Neumann A; Marijon E; de Peretti C; Weill A; Ricordeau P; Danchin N; Allemand H
Arch Cardiovasc Dis; 2011 May; 104(5):332-42. PubMed ID: 21693370
[TBL] [Abstract][Full Text] [Related]
4. Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure.
Nichols CI; Vose JG; Mittal S
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873688
[TBL] [Abstract][Full Text] [Related]
5. Causes and predictors of 30-day readmission after cardiovascular implantable electronic devices implantation: Insights from Nationwide Readmissions Database.
Ahmad S; Munir MB; Sharbaugh MS; Althouse AD; Pasupula DK; Saba S
J Cardiovasc Electrophysiol; 2018 Mar; 29(3):456-462. PubMed ID: 29193418
[TBL] [Abstract][Full Text] [Related]
6. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.
Unsworth JD; Zaidi A; Hargreaves MR
Europace; 2015 Nov; 17(11):1708-11. PubMed ID: 25883081
[TBL] [Abstract][Full Text] [Related]
7. Incidence of device-related infection in 97 750 patients: clinical data from the complete Danish device-cohort (1982-2018).
Olsen T; Jørgensen OD; Nielsen JC; Thøgersen AM; Philbert BT; Johansen JB
Eur Heart J; 2019 Jun; 40(23):1862-1869. PubMed ID: 31155647
[TBL] [Abstract][Full Text] [Related]
8. Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta-analysis.
Rattanawong P; Kewcharoen J; Mekraksakit P; Mekritthikrai R; Prasitlumkum N; Vutthikraivit W; Putthapiban P; Dworkin J
J Cardiovasc Electrophysiol; 2019 Jul; 30(7):1053-1065. PubMed ID: 30938929
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study.
Rennert-May E; Chew D; Lu S; Chu A; Kuriachan V; Somayaji R
Heart Rhythm; 2020 Jul; 17(7):1125-1131. PubMed ID: 32087358
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors and Temporal Trends of Complications Associated With Transvenous Implantable Cardiac Defibrillator Leads.
Koneru JN; Jones PW; Hammill EF; Wold N; Ellenbogen KA
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29748177
[TBL] [Abstract][Full Text] [Related]
11. Cardiac Implantable Electronic Device-Related Infection and Extraction Trends in the U.S.
Sridhar AR; Lavu M; Yarlagadda V; Reddy M; Gunda S; Afzal R; Atkins D; Gopinathanair R; Dawn B; Lakkireddy DR
Pacing Clin Electrophysiol; 2017 Mar; 40(3):286-293. PubMed ID: 28084622
[TBL] [Abstract][Full Text] [Related]
12. CIED infection with either pocket or systemic infection presentation--complete device removal and long-term antibiotic treatment; long-term outcome.
Ihlemann N; Møller-Hansen M; Salado-Rasmussen K; Videbæk R; Moser C; Iversen K; Bundgaard H
Scand Cardiovasc J; 2016; 50(1):52-7. PubMed ID: 26485501
[TBL] [Abstract][Full Text] [Related]
13. Economic impact of cardiac implantable electronic device infections: cost analysis at one year in a large U.S. health insurer.
Eby EL; Bengtson LGS; Johnson MP; Burton ML; Hinnenthal J
J Med Econ; 2020 Jul; 23(7):698-705. PubMed ID: 32255386
[No Abstract] [Full Text] [Related]
14. Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial.
Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Love JC; Augostini R; Faerestrand S; Wiggins SS; Healey JS; Holbrook R; Lande JD; Lexcen DR; Willey S; Tarakji KG;
Circ Arrhythm Electrophysiol; 2020 May; 13(5):e008280. PubMed ID: 32281393
[TBL] [Abstract][Full Text] [Related]
15. Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences.
Nery PB; Fernandes R; Nair GM; Sumner GL; Ribas CS; Menon SM; Wang X; Krahn AD; Morillo CA; Connolly SJ; Healey JS
J Cardiovasc Electrophysiol; 2010 Jul; 21(7):786-90. PubMed ID: 20102431
[TBL] [Abstract][Full Text] [Related]
16. Cardiac Implantable Electronic Device Infection: Detailed Analysis of Cost Implications.
Gitenay E; Molin F; Blais S; Tremblay V; Gervais P; Plourde B; Jacques F; Steinberg C; Sarrazin JF; Charbonneau É; Parent H; O'Hara GE; Champagne J; Philippon F
Can J Cardiol; 2018 Aug; 34(8):1026-1032. PubMed ID: 30049357
[TBL] [Abstract][Full Text] [Related]
17. Incidence, Treatment Intensity, and Incremental Annual Expenditures for Patients Experiencing a Cardiac Implantable Electronic Device Infection: Evidence From a Large US Payer Database 1-Year Post Implantation.
Sohail MR; Eby EL; Ryan MP; Gunnarsson C; Wright LA; Greenspon AJ
Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27506820
[TBL] [Abstract][Full Text] [Related]
18. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
[TBL] [Abstract][Full Text] [Related]
19. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
[TBL] [Abstract][Full Text] [Related]
20. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
